Top

A -- Novel Polybenzimidazole (PBI) Derivatives

Active

07-10Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

This contract involves the development and commercialization of novel polybenzimidazole (PBI) derivatives by the Idaho National Laboratory (INL). Traditional PBIs are valued for their ability to resist deformation at high temperatures, making them suitable for heat-resistant clothing, aerospace components, and braided packaging. However, their application has been restricted primarily to fiber fabrication due to synthesis limitations. The INL has innovated a method to produce PBI derivatives that can form films and other structures, greatly expanding their potential uses, especially in high-temperature membrane applications. These new derivatives are more soluble in common organic solvents such as tetrahydrofuran, methylene chloride, and chloroform, and the synthetic process is efficient, occurring at room temperature with nearly quantitative yields. The resulting materials maintain or improve upon the original PBIs' desirable properties, including enhanced performance in membrane gas testing. The INL holds a patent pending on this synthesis process and is seeking qualified industrial partners interested in licensing the technology either exclusively or non-exclusively. Interested parties are invited to engage with the laboratory before a specified deadline to discuss licensing arrangements and implementation. The opportunity was posted in April 2007 under solicitation number 07-10, associated with NAICS code 326199. The primary contacts for inquiries and further information include Jason Stolworthy, who handles licensing and business communications, and Steve Paschke. This contract represents a promising advancement in high-performance polymer materials with broad industrial applications.

General Info

INL offers licensing for novel, high-temperature resistant polybenzimidazole derivatives with broad applications.

Agency

N/A

NAICS

326199 - All Other Plastics Product Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedApr 25

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyN/A

Contacts1 person available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

Contacts

Steve D Paschke

contact@example.gov

+1 (555) 000-0000

Full Description

Polybenzimidazole (PBI) compounds have unique properties that allow them to resist deformation under high temperatures. For this reason PBIs are used in products such as heat resistant clothing, aircraft, and braided packaging. However, the use of PBIs is limited because the current method of synthesis only allows for fabrication of fibers, not films and other structures. The Idaho National Laboratory (INL) has discovered a method that allows for the fabrication of PBI derivatives that can be used to form films and other structures. This allows for use of PBIs in membranes for high temperature applications and other products. The INL has discovered several different N-substituent carboxyl polybenzimidazole derivatives which are much more soluble in organic solvents than the parent polybenzimidazole. A synthetic route was found that gives a modified PBI that is soluble in tetrahydrofuran (THF), methylene chloride, and chloroform. The modified pathway provides a straightforward post-polymerization synthetic modification that can be carried out at room temperature and gives nearly quantitative yields. Analysis has shown that the method provides high yields of PBI derivatives which retain or exceed the beneficial properties of current PBI compounds. In addition, membrane gas testing showed values that are higher than the parent polymer. The INL is soliciting interest from qualified industrial firms interested in commercializing this technology. The INL has a patent pending on the process which may be licensed exclusively or non-exclusively. See U.S. Patent Application No. 10/969,456. The INL invites interested parties to contact us regarding the details of licensing and implementing this technology into an operation. Interested parties should respond on or before June 1st, 2007. For questions regarding the technology, licensing, and working with the INL, please contact Jason Stolworthy. BUSINESS POINT OF CONTACT: Jason C. Stolworthy, J.D., M.S. (ChE) Telephone: +1 (555) 000-0000 E-Mail: contact@example.gov

Similar Contracts

Same NAICS industry code